An Interactive Web-Based Simulation Architecture for Modeling Chronic Myeloid Leukemia Pathogenesis, Targeted Imatinib Pharmacodynamics, And Hematologic Response Trajectories
INTERNATIONAL JOURNAL OF ADVANCES IN SIGNAL AND IMAGE SCIENCES · 08.10.2026 · 12 (10s) · 72-90
DOI: 10.29284/dtbv5s29 ↗Kurz gefasst
Fachartikel in der Zeitschrift INTERNATIONAL JOURNAL OF ADVANCES IN SIGNAL AND IMAGE SCIENCES, online erschienen am 08.10.2026. Verfasst von V Srinivasan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Targeted therapeutic management of Chronic Myeloid Leukemia using the Breakpoint Cluster Region Abelson murine leukemia viral oncogene homolog1 tyrosine kinase inhibitor TKI Imatinib requires an intuitive grasp of multiscale disease dynamics, yet conventional pedagogical tools often fail to bridge mathematical pharmacology with observable hematology. This study designs, implements, and validates a unified client side four module simulation engine that models CML pathogenesis, physiological hemodynamics, and dose dependent Imatinib pharmacodynamics using open web standards HTML5, CSS3, JavaScript, and SVG. Integrating patient specific baseline biomarkers including age, platelets, initial leukemic burden, and daily dosing regimens of 400 mg or 600 mg, the mathematical engine simulates cellular reduction kinetics and platelet reconstitution over a ninety day protocol. The computational simulation revealed a distinct biphasic therapeutic clearance profile where peripheral leukocytes normalized to baseline physiological thresholds between 4000 and 10000 cells per microliter within approximately 30 days, satisfying complete hematologic remission criteria, whereas oncogenic BCR ABL positive clones decayed exponentially with an elimination rate constant of 0.012, yielding an overall cell destruction efficiency exceeding 65 percent and a corresponding elevation in the composite Overall Response Index. The integrated stacked bar graphical interface visualizes the crucial clinical divergence between rapid hematologic symptom resolution and the persistent residual clone burden observed at day ninety. Ultimately, this zero footprint web framework delivers an accessible cross platform instructional and translational tool that clarifies why sustained TKI maintenance is essential to suppress leukemic stem cells and avert secondary resistance mutations.
Zitieren
APA
Srinivasan, V., Soumya, D. S., & Shetty, D. S. P. (2026). An Interactive Web-Based Simulation Architecture for Modeling Chronic Myeloid Leukemia Pathogenesis, Targeted Imatinib Pharmacodynamics, And Hematologic Response Trajectories. INTERNATIONAL JOURNAL OF ADVANCES IN SIGNAL AND IMAGE SCIENCES, 12(10s), 72-90. https://doi.org/10.29284/dtbv5s29
Vancouver
Srinivasan V, Soumya DS, Shetty DSP. An Interactive Web-Based Simulation Architecture for Modeling Chronic Myeloid Leukemia Pathogenesis, Targeted Imatinib Pharmacodynamics, And Hematologic Response Trajectories. INTERNATIONAL JOURNAL OF ADVANCES IN SIGNAL AND IMAGE SCIENCES. 2026;12(10s):72-90. doi:10.29284/dtbv5s29
BibTeX
@article{Srinivasan2026,
author = {Srinivasan, V and Soumya, Dr. S and Shetty, Dr. Sirish Panduranga},
title = {An Interactive Web-Based Simulation Architecture for Modeling Chronic Myeloid Leukemia Pathogenesis, Targeted Imatinib Pharmacodynamics, And Hematologic Response Trajectories},
journal = {INTERNATIONAL JOURNAL OF ADVANCES IN SIGNAL AND IMAGE SCIENCES},
year = {2026},
volume = {12},
number = {10s},
pages = {72--90},
doi = {10.29284/dtbv5s29}
}
EUVIMED